共 131 条
[1]
Levine GN(2016)2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST elevation myocardial infarction J Am Coll Cardiol 67 1235-1250
[2]
Bates ER(2014)Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure PLoS ONE 9 e100618-568
[3]
Blankenship JC(2019)Acute renal impairment in older adults treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction Coron Artery Dis 30 564-204
[4]
Bailey SR(2013)Does serum bilirubin level on admission predict TIMI flow grade and in-hospital MACE in patients with STEMI undergoing primary PCI Angiology 65 198-223
[5]
Bittl JA(2017)Management of no-reflow phenomenon in the catheterization laboratory J Am Coll Cardiol 10 215-110
[6]
Cercek B(2016)Morphological predictors for no reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture Eur Heart J Cardiovasc Imaging 18 103-313
[7]
Abe S(2018)2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Kardiol Pol 76 229-2035
[8]
Yoshihisa A(2012)Third universal definition of myocardial infarction Circulation 126 2020-957
[9]
Mai T(2008)Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory Catheter Cardiovasc Interv 72 950-1250
[10]
Shimizu T(2018)Risk prediction in infective endocarditis by modifed MELD-XI score Eur J Clin Microbiol Infect Dis 37 1243-674